Atlas Trials

Comparing Efficacy and Safety of Telitacicept and Belimumab in Lupus Nephritis: A Retrospective Multicenter Cohort Study.

Clinical trial NCT07031674 · COMPLETED

Trial details

NCT number
NCT07031674
Sponsor
Yipeng Liu
Status
COMPLETED
Study type
OBSERVATIONAL
Lupus NephritisBelimumab
Start date
2025-10-01
Primary completion
2025-12-31
Enrollment
56

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.